UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 993

Sortiert nach

Antifungal susceptibility of non-albicans Candida spp. isolated from raw milk and human blood in Alborz and Tehran provinces

Iranian journal of microbiology, 2019-12, Vol.11 (6), p.520-526

2019

Link zum Volltext

Verfügbarkeit prüfen

Azole Antifungal Resistance in Candida albicans and Emerging Non- albicans Candida Species

Frontiers in microbiology, 2017-01, Vol.7, p.2173-2173

2017

Link zum Volltext

Verfügbarkeit prüfen

Asymmetric synthesis of (R)-1,3-butanediol from 4-hydroxy-2-butanone by a newly isolated strain Candida krusei ZJB-09162

Applied microbiology and biotechnology, 2012-05, Vol.94 (4), p.969-976

2012

Link zum Volltext

Verfügbarkeit prüfen

Screening and identification of yeasts for decolorizing synthetic dyes in industrial wastewater

International biodeterioration & biodegradation, 2005-09, Vol.56 (2), p.109-114

2005

Link zum Volltext

Verfügbarkeit prüfen

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel

Clinical infectious diseases, 2018-05, Vol.66 (11), p.1678-1686

2018

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

PloS one, 2014-07, Vol.9 (7), p.e101510-e101510

2014

Link zum Volltext

Verfügbarkeit prüfen

Update on Candida krusei, a potential multidrug-resistant pathogen

Medical mycology (Oxford), 2021-01, Vol.59 (1), p.14-30

2021

Link zum Volltext

Verfügbarkeit prüfen

Coronary vasculitis induced in mice by the cell wall mannoprotein of Candida krusei

Biological and Pharmaceutical Bulletin, 2020, pp.b19-01060

2020

Link zum Volltext

Verfügbarkeit prüfen

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2571-2581

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011

Antimicrobial Agents and Chemotherapy, 2014-03, Vol.58 (3), p.1529-1537

2014

Link zum Volltext

Verfügbarkeit prüfen

Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names

PLoS pathogens, 2018-07, Vol.14 (7), p.e1007138-e1007138

2018

Link zum Volltext

Verfügbarkeit prüfen

Probiotic Yeasts Inhibit Virulence of Non -albicans Candida Species

mBio, 2019-10, Vol.10 (5)

2019

Link zum Volltext

Verfügbarkeit prüfen

AML-330 Management of Candida Krusei Candidemia in Patients With Acute Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S237

2022

Link zum Volltext

Verfügbarkeit prüfen

Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation

Scientific reports, 2020-03, Vol.10 (1), p.3814-3814, Article 3814

2020

Link zum Volltext

Verfügbarkeit prüfen

Whole genome sequencing data of Candida krusei, pathogen causing Candidaemia, from Department of Parasitology Culture Collection, Faculty of Medicine Universitas Indonesia [version 1; peer review: 1 approved, 1 approved with reservations]

F1000 research, 2022, Vol.11, p.593

2022

Link zum Volltext

Verfügbarkeit prüfen

Candida albicans Triggers NLRP3-Mediated Pyroptosis in Macrophages

Eukaryotic Cell, 2014-02, Vol.13 (2), p.329-340

2014

Link zum Volltext

Verfügbarkeit prüfen

Emerging opportunistic yeast infections

The Lancet infectious diseases, 2011-02, Vol.11 (2), p.142-151

2011

Link zum Volltext

Verfügbarkeit prüfen

Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1181-1187

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI-TOF MS identification

Mycoses, 2023-11, Vol.66 (11), p.977-983

2023

Link zum Volltext

Verfügbarkeit prüfen

Breakthrough candidaemia in the era of broad-spectrum antifungal therapies: Mycology

Clinical microbiology and infection, 2016-02, Vol.22 (2), p.181-188

2016

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei: e0136185

PloS one, 2015-08, Vol.10 (8)

2015

Link zum Volltext

Verfügbarkeit prüfen

In vitro assessment of the immobilized mannanase enzyme against infection-causing Candida

Future microbiology, 2023-09, Vol.18 (13), p.885-896

Dikbas, Levent

2023

Link zum Volltext

Verfügbarkeit prüfen

Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella

Medical mycology (Oxford), 2020-01, Vol.58 (1), p.83-92

2020

Link zum Volltext

Verfügbarkeit prüfen

Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital

Antimicrobial agents and chemotherapy, 2015-07, Vol.59 (7), p.3944-3955

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 993

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(927)
Mit Volltextzugriff
(906)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Candida Krusei
(973)
Science & Technology
(813)
Life Sciences & Biomedicine
(765)
Candida Albicans
(495)
Humans
(422)
Microbiology
(397)
Biological And Medical Sciences
(345)
Candida
(310)
Candida Glabrata
(310)
Antifungal Agents - Pharmacology
(286)
Candida Tropicalis
(276)
Candida - Drug Effects
(268)
Candida Parapsilosis
(249)
Infectious Diseases
(247)
Mycology
(238)
Medical Sciences
(231)
Microbial Sensitivity Tests
(227)
Candida - Isolation & Purification
(197)
Antifungal Agents
(196)
Pharmacology & Pharmacy
(168)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Antifungal susceptibility of non-albicans Candida spp. isolated from raw milk and human blood in Alborz and Tehran provinces

Azole Antifungal Resistance in Candida albicans and Emerging Non- albicans Candida Species

Asymmetric synthesis of (R)-1,3-butanediol from 4-hydroxy-2-butanone by a newly isolated strain Candida krusei ZJB-09162

Screening and identification of yeasts for decolorizing synthetic dyes in industrial wastewater

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

Update on Candida krusei, a potential multidrug-resistant pathogen

Coronary vasculitis induced in mice by the cell wall mannoprotein of Candida krusei

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011

Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names

Probiotic Yeasts Inhibit Virulence of Non -albicans Candida Species

AML-330 Management of Candida Krusei Candidemia in Patients With Acute Myeloid Leukemia

Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation

Whole genome sequencing data of Candida krusei, pathogen causing Candidaemia, from Department of Parasitology Culture Collection, Faculty of Medicine Universitas Indonesia [version 1; peer review: 1 approved, 1 approved with reservations]

Candida albicans Triggers NLRP3-Mediated Pyroptosis in Macrophages

Emerging opportunistic yeast infections

Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI-TOF MS identification

Breakthrough candidaemia in the era of broad-spectrum antifungal therapies: Mycology

Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei: e0136185

In vitro assessment of the immobilized mannanase enzyme against infection-causing Candida

Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella

Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital

Suchergebnisse filtern